Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study.
Smith EMD, Egbivwie N, Jorgensen AL, Ciurtin C, Al-Abadi E, Armon K, Bailey K, Brennan M, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, Malik G, McLaren Z, Pilkington C, Ramanan AV, Rangaraj S, Ratcliffe A, Riley P, Sen E, Sridhar A, Wilkinson N, Wood F, Beresford MW, Hedrich CM. Smith EMD, et al. Among authors: hedrich cm. Clin Immunol. 2022 Jun;239:109028. doi: 10.1016/j.clim.2022.109028. Epub 2022 May 2. Clin Immunol. 2022. PMID: 35513304 Free article.
Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
Smith E, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley D, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan A, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM. Smith E, et al. Among authors: hedrich cm. Lupus. 2019 Apr;28(5):613-620. doi: 10.1177/0961203319836712. Epub 2019 Mar 14. Lupus. 2019. PMID: 30871425
Interference of canakinumab with commercial IL-1β ELISAs.
Linge M, Hedrich CM, Rösen-Wolff A, Winkler S. Linge M, et al. Among authors: hedrich cm. Clin Immunol. 2019 Aug;205:6-7. doi: 10.1016/j.clim.2019.05.008. Epub 2019 May 13. Clin Immunol. 2019. PMID: 31096037 No abstract available.
Vasculitis in Juvenile-Onset Systemic Lupus Erythematosus.
Smith EMD, Lythgoe H, Hedrich CM. Smith EMD, et al. Among authors: hedrich cm. Front Pediatr. 2019 May 9;7:149. doi: 10.3389/fped.2019.00149. eCollection 2019. Front Pediatr. 2019. PMID: 31143758 Free PMC article. Review.
Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO.
Ramanan AV, Hampson LV, Lythgoe H, Jones AP, Hardwick B, Hind H, Jacobs B, Vasileiou D, Wadsworth I, Ambrose N, Davidson J, Ferguson PJ, Herlin T, Kavirayani A, Killeen OG, Compeyrot-Lacassagne S, Laxer RM, Roderick M, Swart JF, Hedrich CM, Beresford MW. Ramanan AV, et al. Among authors: hedrich cm. PLoS One. 2019 Jun 5;14(6):e0215739. doi: 10.1371/journal.pone.0215739. eCollection 2019. PLoS One. 2019. PMID: 31166977 Free PMC article.
Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
Massias JS, Smith EMD, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM. Massias JS, et al. Among authors: hedrich cm. Lupus. 2020 Apr;29(5):474-481. doi: 10.1177/0961203320909156. Epub 2020 Mar 31. Lupus. 2020. PMID: 32233733 Free PMC article.
171 results